Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto.

Schedule

*Product:*	Halaven
Active Ingredient:	Eribulin mesilate 0.5mg/mL equivalent to eribulin 0.44mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Eisai New Zealand Limited
Manufacturers:	NerPharMa SRL, Nerviano, Italy BSP Pharmaceuticals SpA, Latina, Italy

Dated this 19th day of April 2024.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule